His main research concerns Immunology, Immune system, Inflammation, IL-2 receptor and Cell biology. Louis Boon regularly links together related areas like CD40 in his Immunology studies. His research integrates issues of Cytotoxic T cell, Cancer research and Antigen in his study of Immune system.
Louis Boon combines subjects such as B7-H1 Antigen, Psoriasis, Endocrinology and Signal transduction with his study of Inflammation. His IL-2 receptor study incorporates themes from Prebiotic, Interleukin 21, Sensitization, Immunoglobulin E and FOXP3. He interconnects Receptor, IRF8 and B cell in the investigation of issues within Cell biology.
His primary areas of investigation include Immunology, Immune system, Inflammation, Cancer research and T cell. Louis Boon has researched Immunology in several fields, including Cytotoxic T cell and CD40. Louis Boon focuses mostly in the field of Immune system, narrowing it down to matters related to Cytokine and, in some cases, Tumor necrosis factor alpha.
His studies in Inflammation integrate themes in fields like Endocrinology and Signal transduction. In his research, Dendritic cell and Glioma is intimately related to Immunotherapy, which falls under the overarching field of Cancer research. His research on T cell often connects related areas such as Cell biology.
Louis Boon mainly investigates Immunology, Cancer research, Immune system, Inflammation and Immunotherapy. In his research on the topic of Immunology, Immunity is strongly related with Cytotoxic T cell. His study on Cancer research also encompasses disciplines like
His Immune system study combines topics from a wide range of disciplines, such as Myeloid and Antibody. The Inflammation study combines topics in areas such as Germinal center, Innate immune system, Innate lymphoid cell and Lung. His work in the fields of Immunotherapy, such as Cancer immunotherapy, overlaps with other areas such as Vorinostat.
Immunology, Cancer research, Immune system, Immunotherapy and Tumor microenvironment are his primary areas of study. His study looks at the relationship between Immunology and topics such as Cytotoxic T cell, which overlap with FOXP3 and Immunity. The various areas that he examines in his Cancer research study include Regeneration, CD40, Lymphatic vessel and Lymph.
His Immune system research integrates issues from Cytokine and Antigen. The study incorporates disciplines such as Dendritic cell, Autoimmunity, NOD mice and Indoleamine 2,3-dioxygenase in addition to Immunotherapy. His Tumor microenvironment research is multidisciplinary, relying on both PD-L1 and Glioma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
Leslie van der Fits;Sabine Mourits;Jane S. A. Voerman;Marius Kant.
Journal of Immunology (2009)
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
Maria T Pallotta;Ciriana Orabona;Claudia Volpi;Carmine Vacca.
Nature Immunology (2011)
Aryl hydrocarbon receptor control of a disease tolerance defence pathway
Alban Bessede;Alban Bessede;Marco Gargaro;Maria T. Pallotta;Davide Matino.
Nature (2014)
Comparative In Vitro Immune Stimulation Analysis of Primary Human B Cells and B Cell Lines.
Kristien Van Belle;Jean Herman;Louis Boon;Mark Waer.
Clinical & Developmental Immunology (2016)
Transfer of Central Nervous System Autoantigens and Presentation in Secondary Lymphoid Organs
Alex F. de Vos;Marjan van Meurs;Herbert P. Brok;Leonie A. Boven.
Journal of Immunology (2002)
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy.
Ursula Grohmann;Claudia Volpi;Francesca Fallarino;Silvia Bozza.
Nature Medicine (2007)
Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages.
Leonie A. Boven;Marjan van Meurs;Rolf G. Boot;Atul Mehta.
American Journal of Clinical Pathology (2004)
Infection with a helminth parasite attenuates autoimmunity through TGF-β-mediated suppression of Th17 and Th1 responses.
Kevin P. Walsh;Miriam T. Brady;Conor M. Finlay;Louis Boon.
Journal of Immunology (2009)
Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis
Dirk Lievens;Dirk Lievens;Alma Zernecke;Tom Seijkens;Oliver Soehnlein.
Blood (2010)
CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.
Oliver M. Grauer;Stefan Nierkens;Erik Bennink;Liza W.J. Toonen.
International Journal of Cancer (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Ghent University
KU Leuven
Ludwig-Maximilians-Universität München
Utrecht University
University Medical Center Groningen
University of Perugia
University of Perugia
University of Perugia
Ghent University
Dartmouth College
University of Applied Sciences and Arts Northwestern Switzerland
Centre national de la recherche scientifique, CNRS
Cornell University
University of Copenhagen
University of Geneva
Imperial College London
University of Glasgow
French National Museum of Natural History
Nagoya University
The Ohio State University
University of Rhode Island
Vancouver General Hospital
Roswell Park Cancer Institute
University Health Network
University of Florida
University of California, Berkeley